726 related articles for article (PubMed ID: 25479037)
1. Cancer stem cells: the 'Achilles heel' of chemo-resistant tumors.
Hong IS; Lee HY; Nam JS
Recent Pat Anticancer Drug Discov; 2015; 10(1):2-22. PubMed ID: 25479037
[TBL] [Abstract][Full Text] [Related]
2. Understanding and targeting cancer stem cells: therapeutic implications and challenges.
Chen K; Huang YH; Chen JL
Acta Pharmacol Sin; 2013 Jun; 34(6):732-40. PubMed ID: 23685952
[TBL] [Abstract][Full Text] [Related]
3. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
[TBL] [Abstract][Full Text] [Related]
4. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; PĆ¼tzer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
5. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
6. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
Safa AR
Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic approaches targeting cancer stem cells.
Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
[TBL] [Abstract][Full Text] [Related]
8. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.
Ranji P; Salmani Kesejini T; Saeedikhoo S; Alizadeh AM
Tumour Biol; 2016 Oct; 37(10):13059-13075. PubMed ID: 27561758
[TBL] [Abstract][Full Text] [Related]
9. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicine-mediated cancer stem cell therapy.
Shen S; Xia JX; Wang J
Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
[TBL] [Abstract][Full Text] [Related]
11. [Cancer Stem Cells (CSCs) as a Rational Therapeutic Cancer Target, and Screening for CSC-targeting Drugs].
Mashima T
Yakugaku Zasshi; 2017; 137(2):129-132. PubMed ID: 28154319
[TBL] [Abstract][Full Text] [Related]
12. Implications of cancer stem cells in the treatment of cancer.
Pan CX; Zhu W; Cheng L
Future Oncol; 2006 Dec; 2(6):723-31. PubMed ID: 17155899
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cell (CSC) inhibitors: a review of recent patents (2012-2015).
Kharkar PS
Expert Opin Ther Pat; 2017 Jul; 27(7):753-761. PubMed ID: 28460551
[TBL] [Abstract][Full Text] [Related]
14. Natural Compounds Targeting Cancer Stem Cells: A Promising Resource for Chemotherapy.
Das PK; Zahan T; Abdur Rakib M; Khanam JA; Pillai S; Islam F
Anticancer Agents Med Chem; 2019; 19(15):1796-1808. PubMed ID: 31272363
[TBL] [Abstract][Full Text] [Related]
15. Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance.
Keyvani-Ghamsari S; Khorsandi K; Rasul A; Zaman MK
Clin Epigenetics; 2021 May; 13(1):120. PubMed ID: 34051847
[TBL] [Abstract][Full Text] [Related]
16. Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents.
Zhou HM; Zhang JG; Zhang X; Li Q
Signal Transduct Target Ther; 2021 Feb; 6(1):62. PubMed ID: 33589595
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cells and novel targets for antitumor strategies.
Prud'homme GJ
Curr Pharm Des; 2012; 18(19):2838-49. PubMed ID: 22390767
[TBL] [Abstract][Full Text] [Related]
18. Cancer Stem Cells and Targeting Strategies.
Barbato L; Bocchetti M; Di Biase A; Regad T
Cells; 2019 Aug; 8(8):. PubMed ID: 31426611
[TBL] [Abstract][Full Text] [Related]
19. Can nanomedicines kill cancer stem cells?
Zhao Y; Alakhova DY; Kabanov AV
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1763-83. PubMed ID: 24120657
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells.
Hajizadeh F; Okoye I; Esmaily M; Ghasemi Chaleshtari M; Masjedi A; Azizi G; Irandoust M; Ghalamfarsa G; Jadidi-Niaragh F
Life Sci; 2019 Nov; 237():116952. PubMed ID: 31622608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]